Table 1 Baseline characteristics of the participants across the treatment groups.
Characteristics | Treatment Group | |||
|---|---|---|---|---|
Favipiravir | Hydroxychloroquine | Standard Care | P-value* | |
N | 54 | 51 | 52 | |
Age [median (IQR)] | 44.5 (33.0, 50.0) | 40.0 (34.0, 56.0) | 48.5 (35.5, 57.0) | 0.17 |
BMI, Kg/m2 [median (IQR)] | 29.6 (25.6, 31.6) | 27.9 (24.2, 32.1) | 28.7 (26.4, 32.5) | 0.56 |
Male [n(%)] | 23 (43%) | 25 (50%) | 27 (52%) | 0.60 |
Smoker [n(%)] | 0 (0%) | 2 (4%) | 3 (6%) | 0.21 |
Diabetes [n(%)] | 12 (22%) | 9 (18%) | 20 (38%) | 0.040 |
Heart Disease [n(%)] | 1 (2%) | 0 (0%) | 1 (2%) | 0.61 |
Chronic Lung Disease or Asthma [n(%)] | 6 (11%) | 2 (4%) | 4 (8%) | 0.38 |
Shortness of Breath [n(%)] | 14 (26%) | 15 (29%) | 18 (35%) | 0.62 |
Oxygen therapy administered [n(%)] | 0 (0%) | 0 (0%) | 1 (2%) | 0.36 |
Ventilation Required [n(%)] | 0 (0%) | 0 (0%) | 1 (2%) | 0.36 |
Temperature, °C [median (IQR)] | 36.8 (36.6, 37.0) | 36.8 (36.8, 37.1) | 36.8 (36.6, 37.0) | 0.49 |
Systolic BP, mmHg [median (IQR)] | 122.0 (110.0, 136.0) | 120.0 (114.0, 133.0) | 122.5 (112.0, 134.5) | 0.87 |
Diastolic BP, mmHg [median (IQR)] | 75.0 (70.0, 83.0) | 72.0 (65.0, 79.0) | 72.0 (64.0, 79.0) | 0.22 |
Respiratory rate, breaths/min, [median (IQR)] | 18.0 (18.0, 20.0) | 18.0 (18.0, 20.0) | 18.0 (18.0, 20.0) | 0.83 |
Heart rate, beats/min, [median (IQR)] | 80.0 (73.0, 89.0) | 84.0 (77.0, 90.0) | 83.0 (73.5, 89.5) | 0.51 |
Oxygen Saturation, mmHg [median (IQR)] | 98.0 (96.0, 99.0) | 98.0 (96.0, 98.0) | 97.0 (96.0, 98.0) | 0.17 |
